CD9 and cancer: In xenograft mouse models of human breast cancer, administration of anti-CD9 and anti-CD63 antibodies suppressed the spread of cancer cells to lymph nodes, lungs, and the thoracic cavity by targeting cancer-derived sEVs carrying CD9 and CD63 (212).